Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2025-08-07 00:00:00 ET · period of report 2025-08-06 · accession 0000875320-25-000218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-07 | 2025-08-06 | VRTX | SACHS BRUCE I | Dir | P - Purchase | $389.68 | +5,000 | 45.0K | +12% | +$1.95M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-06 | P | A | 1,634 | $389.36 | 41,634 | D | — | — | (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F1) Open market purchases reported on this line occurred at a weighted average price of $389.36 (range $388.61 to $389.60). |
| 2 | Common | Common Stock | 2025-08-06 | P | A | 3,366 | $389.84 | 45,000 | D | — | — | (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F3) Open market purchases reported on this line occurred at a weighted average price of $389.84 (range $389.61 to $390.00). |